CpG Inhibits Pro-B Cell Expansion through a Cathepsin B-Dependent Mechanism
Author(s) -
Ana I. Lalanne,
Ignacio Moraga,
Yi Hao,
João P. Pereira,
Nuno L. Alves,
Nicholas D. Huntington,
António A. Freitas,
Ana Cumano,
Paulo Vieira
Publication year - 2010
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.0903854
Subject(s) - tlr9 , lymphopoiesis , microbiology and biotechnology , b cell , cathepsin b , biology , cpg site , progenitor cell , chemistry , immunology , stem cell , gene , gene expression , antibody , biochemistry , enzyme , dna methylation
TLR9 is expressed in cells of the innate immune system, as well as in B lymphocytes and their progenitors. We investigated the effect of the TLR9 ligand CpG DNA on the proliferation of pro-B cells. CpG DNA inhibits the proliferation of pro-B, but not pre-B, cells by inducing caspase-independent cell death through a pathway that requires the expression of cathepsin B. This pathway is operative in Rag-deficient mice carrying an SP6 transgene, in which B lymphopoiesis is compromised, to reduce the size of the B lymphocyte precursor compartments in the bone marrow. Thus, TLR9 signals can regulate B lymphopoiesis in vivo.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom